Cancer Center Switches Focus on Fund-Raising as Problems Mount
By KATIE THOMAS and CHARLES ORNSTEIN from NYT Health https://ift.tt/2Du1PSX
Single psilocybin trip delivers two years of depression relief for cancer patients
Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in cancer patients. In a groundbreaking trial, a single dose combined with therapy significantly reduced emotional suffering, and these effects often lasted over two years. As follow-up studies expand the research to multiple doses and larger samples, scientists are eyeing a possible new standard of care that merges psychedelics with psychological support. from Latest Science News -- ScienceDaily https://ift.tt/P1Aoby3
Comments
Post a Comment